Navigation Links
Bionovo Receives Positive Guidance from FDA on Menerba®
Date:8/30/2010

early and mid-stage clinical trials, Bionovo believes they have discovered new classes of drug candidates within their rich pipeline with the potential to be leaders in their markets. Bionovo is headquartered in Emeryville, California and is traded on the NASDAQ Capital Market under the symbol, "BNVI". For more information about Bionovo and its programs, visit http://www.bionovo.com.

Forward Looking Statements

This release contains certain forward-looking statements relating to the business of Bionovo, Inc. that can be identified by the use of forward-looking terminology such as "believes," "expects," or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties, including uncertainties relating to product development, efficacy and safety, regulatory actions or delays, the ability to obtain or maintain patent or other proprietary intellectual property protection, market acceptance, physician acceptance, third party reimbursement, future capital requirements, competition in general and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Certain of these risks and uncertainties are or will be described in greater detail in our filings with the Securities and Exchange Commission, which are available at http://www.sec.gov. Bionovo, Inc. is under no obligation (and expressly disclaims any such obligation) to update or alter its forward-looking statements whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Bionovo, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Bionovo Announces Reverse Stock Split
2. Bionovo Announces Publication Describing Menerbas Effect on Neural Pathways Related to Temperature Regulation
3. Bionovo to Advance Menerba to Phase 3 Clinical Testing in Europe
4. Bionovo, Inc. to Announce Second Quarter Fiscal Year 2010 Financial Results on Wednesday, August 4, 2010
5. Bionovo Announces a $15 Million At-The-Market Firm Commitment Financing Agreement
6. Bionovo Announces 2009 Highlights and Year-End Financial Results
7. Bionovo, Inc. to Announce Fourth Quarter and Fiscal Year 2009 Financial Results on Monday, March 15, 2010
8. Bionovo Announces Publication of Positive Results From the Phase 1B Clinical Trial of Bezielle (BZL101) for Metastatic Breast Cancer
9. Bionovo Announces Third Quarter 2009 Highlights and Financial Results
10. Bionovo, Inc. to Announce Third Quarter Fiscal Year 2009 Financial Results on Thursday, November 5, 2009
11. Bionovo Announces Publication of Data on Potential Increase in Breast Cancer Risk Due to the Inhibitory Effect of Tamoxifen Treatment on Estrogen Receptor Beta
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... Rogne Bioscience, a privately-held biotechnology company developing ... and mechanism of action data will be presented during ... (SID) Annual Meeting being held May 6-9, 2015 at ... . Logo - http://photos.prnewswire.com/prnh/20150501/213318LOGO ... novel, low MW (<1700 daltons) peptide as a topical ...
(Date:5/4/2015)... , May 4, 2015  By looking at ... to distinguish between two very different conditions that ... Theodore Henderson , MD, PhD., a ... cases, this study can help the ... therefore treatment options, for Post-Traumatic Stress Disorder (PTSD) ...
(Date:5/4/2015)... 4, 2015  CytRx Corporation (Nasdaq: CYTR ... in oncology, today announced an interim analysis from ... pairing aldoxorubicin with either gemcitabine or ifosfamide. Both ... with escalating doses of aldoxorubicin. The combinations appear ... lowest dose level of aldoxorubicin (170 mg/m2), impressive ...
Breaking Medicine Technology:Rogne Bioscience to Present Data from Topical Biologic Psoriasis Program at Upcoming SID Annual Meeting 2015 2New Medical Research Shows Brain Imaging Can Now Help Doctors Differentiate Between PTSD and Traumatic Brain Injuries 2New Medical Research Shows Brain Imaging Can Now Help Doctors Differentiate Between PTSD and Traumatic Brain Injuries 3CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 2CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 3CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 4CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 5CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 6CytRx Reports Aldoxorubicin Demonstrates Both Tumor Shrinkage and Improved Quality of Life in Chemotherapy Resistant Cancers 7
... HILL, N.J. and ATLANTA, Feb. 9, 2012  Glowpoint, Inc. ... provider of cloud managed video services , today ... a leader in designing and integrating operating rooms, has ... video platform for videoconferencing and broadcasting from operating rooms. ...
... Mylan Inc. (Nasdaq: MYL ) CEO Heather Bresch ... Commerce Committee at a hearing hosted by the subcommittee on ... User Fees and Further Examination of Drug Shortages." ... peace of mind in knowing that every prescription, brand or ...
Cached Medicine Technology:Stryker Communications Selects Glowpoint to Enhance IP Video Platform for Operating Rooms 2Stryker Communications Selects Glowpoint to Enhance IP Video Platform for Operating Rooms 3Mylan CEO Heather Bresch Testifies Before Congress in Support of Generic Drug User Fee Program and Urges Update of Federal Food, Drug and Cosmetic Act of 1938 to Create a Level Playing Field for Manufacturers 2Mylan CEO Heather Bresch Testifies Before Congress in Support of Generic Drug User Fee Program and Urges Update of Federal Food, Drug and Cosmetic Act of 1938 to Create a Level Playing Field for Manufacturers 3Mylan CEO Heather Bresch Testifies Before Congress in Support of Generic Drug User Fee Program and Urges Update of Federal Food, Drug and Cosmetic Act of 1938 to Create a Level Playing Field for Manufacturers 4
(Date:5/4/2015)... May 04, 2015 In a continuing ... for substance absue, Per Wickstrom, the founder of Choices ... Lounge and the “Salute to the Oscars” celebration ... on the top floor of the luxurious Beverly Hilton ... top producer of sustainable product placement in TV and ...
(Date:5/4/2015)... Each year, the Susan G. Komen organization hosts ... for breast cancer. This year, Dr. Mark Deutsch and his ... entertainment sponsor for the 25th annual Susan G. Komen Greater ... Lenox Square Mall. , The Komen organization hopes have 10,000 ... million. Perimeter Plastic Surgery has not only taken on the ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 “ LiveSchool ... monthly AppWatch, which takes a look at the latest ... and Windows. Joe Toohey, the host of AppWatch and ... viewers how this application allows teachers to reward students ... than some realize, especially in the classroom. And ...
(Date:5/4/2015)... Santa Ana, CA (PRWEB) May 04, 2015 ... and live a full life are the motivating forces behind ... by California clinical psychologist and author Amy L. Stark. , ... and the little girl next door comes from Stark’s desire ... said Stark. “I’ve been a fairy godmother to my neighbors’ ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 The U.S. ... baby boomers join the ranks of senior citizens (1) ... on an already over-burdened healthcare system. Additionally, as older ... to replace them. Per the U.S. Census Bureau, the ... to increase 75% by 2050 while those 25 to ...
Breaking Medicine News(10 mins):Health News:Per Wickstrom Interviews TV and Film Star Carolyn Hennesy About Substance Abuse and Treatment 2Health News:Perimeter Plastic Surgery Sponsors 2015 Susan G. Komen Greater Atlanta "Race for the Cure" 2Health News:An Application for Teachers to Reward Students with Good Behavior Was Featured on NewsWatch Television 2Health News:Introducing New Children’s Book The Fairy Godmother Next Door 2Health News:U.S. Healthcare Worker Shortage Escalating: Sterling Warns Medical Practitioners to Rapidly Reverse Low Employee Retention 2Health News:U.S. Healthcare Worker Shortage Escalating: Sterling Warns Medical Practitioners to Rapidly Reverse Low Employee Retention 3Health News:U.S. Healthcare Worker Shortage Escalating: Sterling Warns Medical Practitioners to Rapidly Reverse Low Employee Retention 4
... Feb. 3 BeneChill, Inc. ( www.benechill.com ) ... Intra-Nasal Cooling Effectiveness) study. This randomized study will ... during resuscitation increases patient resuscitation and survival rates.The ... approval study in Europe. The company received CE ...
... Nearly three out of four Americans (71 ... cost of addiction treatment - yet most consumers ... would pay for substance abuse treatment, according to ... Hazelden, the national nonprofit organization that helps people ...
... ESRX ), one of the largest pharmacy benefit management companies ... quarter earnings,on Wednesday, February 25, 2009 after the market closes ... results on Thursday,February 26, 2009, at 10:00 a.m. Eastern Time ... call is being webcast and can be accessed at Express ...
... be avoided since most symptoms fade within 6 weeks, ... A combination of physical therapy and anti-inflammatory drugs is ... by symptomatic lumbar degenerative disc disease, according to a ... found that in 90 percent of people with low ...
... known that patients with few primary care doctor,s office ... new research indicates that even patients who see their ... study, which appears in the February issue of ... a team of researchers at UC Davis, the University ...
... allied healthcare providers, and policymakers will gather in ... Williamsburg Lodge to learn practical, clinical information on ... and innovative translational research advances that impact patient ... full program, faculty, accreditation, and registration information is ...
Cached Medicine News:Health News:BeneChill Launches European Study of Intra-Arrest Cooling 2Health News:Three-Quarters of Americans Believe Health Insurance Should Pay for Addiction Treatment, Yet Most Don't Know If Their Health Plan Covers Substance-Abuse Care, Says New Hazelden Survey 2Health News:Three-Quarters of Americans Believe Health Insurance Should Pay for Addiction Treatment, Yet Most Don't Know If Their Health Plan Covers Substance-Abuse Care, Says New Hazelden Survey 3Health News:Three-Quarters of Americans Believe Health Insurance Should Pay for Addiction Treatment, Yet Most Don't Know If Their Health Plan Covers Substance-Abuse Care, Says New Hazelden Survey 4Health News:Express Scripts Announces Fourth Quarter 2008 Earnings Conference Call 2Health News:Therapy, Meds Best for Lumbar Low Back Pain 2Health News:Study shows that primary care doctors miss opportunities to recommend colon cancer screening 2Health News:Opinion Leaders in Women’s Health To Take the Podium at the 17th Annual Congress on Women’s Health 2
Titanium 0.18 mm diameter angled tip, 10 mm angled shaft. Used to mark the visual axis. Round knurled handle with dull finish. Overall length: 4.7 inches. Most popular size or model....
0.3 mm hook angled 45 degrees, 9 mm from tip to bend. Flat smooth handle with polished finish. Overall length: 4.6 inches....
Straight 31 mm shaft with flat handle and polished finish. 0.5 mm cup. Overall length: 5 inches....
Round knurled handle with adjustable finger-like tips that rest in the grooved disposable trephine blades. Used with disposable trephine blades. Polished finish. Most popular size or model....
Medicine Products: